Not recruiting
Chronic lymphocytic leukaemia
Not recruitingStudy on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
Registered drugNo placebo
Study on the Safety and Effectiveness of Epcoritamab, Venetoclax, and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
Registered drugNo placebo
- Disease:Chronic lymphocytic leukaemia
- Substances:CyclophosphamideEpcoritamab+7
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Cyclophosphamide



